https://orcid.org/0000-0001-8874-0289
References
- Barrett JS , FosslerMJ , CadieuKD , GastonguayMR. Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings. J. Clin. Pharmacol.48, 632–649 (2008).
- Usman M , KhadkaS , SaleemM , RasheedH , KunwarB , AliM. Pharmacometrics: a new era of pharmacotherapy and drug development in low-and middle-income countries. Adv. Pharmacol. Pharm. Sci.2023, 3081422 (2023).
- McComb M , BiesR , RamanathanM. Machine learning in pharmacometrics: opportunities and challenges. Br. J. Clin. Pharmacol.88, 1482–1499 (2022).
- Chaturvedula A , Calad-ThomsonS , LiuC , SaleM , GattuN , GoyalN. Artificial intelligence and pharmacomterics: time to embrace, capitalize, and advance?CPT Pharmacometrics Syst. Pharmacol.8, 440–443 (2019).
- Harnish L , MathewsI , ChardJ , KarlssonMO. Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development. CPT Pharmacometrics Syst. Pharmacol.2, e34 (2013).
- Quinney SK , BiesRR , GrannisSJet al. The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics. Pharmacotherapy43, 391–402 (2023).
- Darwich AS , OgungbenroK , VinksAAet al. Why has model-informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clin. Pharmacol. Ther.101, 646–656 (2017).
- Cavalli G , HeardE. Advances in epigenetics link genetics to the environment and disease. Nature571, 489–499 (2019).
- Carter B , ZhaoK. The epigenetic basis of cellular heterogeneity. Nat. Rev. Genet.22, 235–250 (2021).
- Li S , NguyenTL , WongEMet al. Genetic and environmental causes of variation in epigenetic aging across the lifespan. Clin. Epigenetics12, 158 (2020).
- Murat K , GrüningB , PoterlowiczPW , WestgateG , TobinDJ , PoterlowiczK. Ewastools: Infinium Human Methylation BeadChip pipeline for population epigenetics integrated into Galaxy. Gigascience9, giaa049 (2020).
- Peedicayil J . Pharmacoepigenetics and pharmacoepigenomics: an overview. Curr. Drug Discov. Technol.16, 392–399 (2019).
- Computational epigenetics and disease. In: Computational Epigenetics and Diseases.WeiLK ( Ed.). Elsevier, London, UK, 1–9 (2019).
- Rauch TA , PfeiferGP. Methods for analyzing DNA cytosine modifications genome-wide. In: Handbook of Epigenetics: The New Molecular and Medical Genetics.TollefsbolTO ( Ed.). Elsevier, London, UK, 123–135 (2023).
- Tian S , SlagerSL , KleeEW , YanH. Genome-wide analyses of histone modifications in the mammalian genome. In: Handbook of Epigenetics: The New Molecular and Medical Genetics.TollefsbolTO (E d.). Elsevier, London, UK, 137–161 (2023).
- Onoguchi-Mizutani R , TaniueK , KawataK , YamadaT , AkimitsuN. Techniques for analyzing genome-wide expression of non-coding RNA. In: Handbook of Epigenetics: The New Molecular and Medical GeneticsTollefsbolTO ( Ed.). Elsevier, London, UK, 163–184(2023).
- Turk D , FuhrLM , MarokFZet al. Novel models for the prediction of drug–gene interactions. Expert. Opin. Drug. Metab. Toxicol.17, 1293–1310 (2021).
- Packiasabapathy S , AruldhasBW , HornNet al. Pharmacogenomics of methadone: a narrative review of the literature. Pharmacogenomics21, 871–887 (2020).
- Uthayopas K , de SáAGC , AlaviA , PiresDEV , AscherDB. TSMDA: target and symptom-based computational model for miRNA–disease-association prediction. Mol. Ther. Nucleic Acids26, 536–546 (2021).
- Turner RM , ParkBK , PirmohamedM. Parsing interindividual drug variability: an emerging role for sytems pharmacology. WIREs Syst. Biol. Med.7, 221–241 (2015).